A Study to Determine the Feasibility of Wireless Electrocardiography
- Conditions
- Atrial FibrillationConduction DefectsNormal Sinus RhythmPremature Atrial and Ventricular Beats
- Interventions
- Device: Observational ambulatory ECG monitoring
- Registration Number
- NCT02162394
- Lead Sponsor
- Peerbridge Health, Inc
- Brief Summary
The investigators are conducting a prospective, observational study to examine the ECG waveforms captured by the new medical device as compared to a traditional Holter monitor for subsequent use in visual diagnoses of atrial and ventricular arrhythmias as well as cardiac impulse and/or conduction disorders by qualified clinicians.
The hypothesis is that this new medical device prototype is non-inferior to traditional Holter monitoring for capturing ECG waveforms that can be visually assessed for atrial and ventricular arrhythmias as well as disorders of cardiac impulse formation and/or conduction.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
- Patients must be at least 18 years of age
- Patients must have a medical indication to wear a Holter monitor
- Patients must not be pregnant
- Patients must be able to comply with the study procedures
- Patients must be willing to participate and able to provide informed consent
- Patients must be willing to wear both devices (Holter and the wireless device prototype) simultaneously and continuously for a 2 to 3 hr period
- Patients who are not able or willing to comply with study procedures
- Patients with an existing implanted cardioverter-defibrillator and/or pacemaker
- Patients with a known life threatening arrhythmia
- Patients who manifest low voltage on their electrocardiogram
- Patients affected by inflammatory and/or infectious skin disorders
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Referred for Holter monitoring Observational ambulatory ECG monitoring -
- Primary Outcome Measures
Name Time Method Percent of 8 second ECG strips of sufficient quality for visual diagnosis 3 hours
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Lenox Hill Hospital
🇺🇸New York, New York, United States